ATNM ▲ +1.0% - Actinium Pharmaceuticals, Inc.
$ATNM ATNM ATNM - Actinium Pharmaceuticals Announces Oral and Poster Presentations at EANM 2026 Highlighting Broad Antitumor Activity of ATNM-400 Across Lung, Colorectal and Ovarian Cancer Models
16-OCT-2026 08:30 AM ET
Share this post
More filings for $ATNM
ATNM ▲ +1.0% - Actinium Pharmaceuticals, Inc.Oct 16, 2026ATNM ▲ +4.2% - Actinium Pharmaceuticals, Inc.Oct 15, 2026ATNM ▲ +2.1% - Actinium Pharmaceuticals, Inc.Oct 15, 2026ATNM ▼ -1.9% - Actinium Pharmaceuticals, Inc.Sep 4, 2026
View full $ATNM filing history →💬 Comments
Loading comments…
Leave a comment